fda tirzepatide approval Approves Mounjaro (tirzepatide) Injection for Diabetes Zepbound (tirzepatide) is the first

Trial STEP TEENS (Weghuber et al., NEJM 2022) Design Phase 3 / 68 weeks Population 201 adolescents (12-17) with obesity Key result -16.1% BMI reduction vs +0.6% placebo

In MCAS, mast cells become hyperactive, degranulating in response to triggers that should not provoke a reaction

As soon as you stop it, youre going to feel really hungry and keeping off those 10 pounds is going to be really difficult

Pumuti kana, kikita kapa

We don't have a physical Greeley clinic all in-person appointments are at our Fort Collins location

Activity changes: Some experience fatigue or reduced energy on GLP-1s, leading to less physical activity and resistance training that would otherwise preserve muscle